DGAP-News: Virpax Pharmaceuticals Inc.: Virpax Pharmaceuticals Announces Pricing of Initial Public Offering Virpax(R) Pharmaceuticals Inc.: Virpax(R) Pharmaceuticals Announces Pricing of Initial Public Offering 17.02.2021 / 05:47 Virpax WEST CHESTER, PA, February 16, 2021 - Virpax (R) Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of its initial public offering of 1,800,000 shares of its common stock at a public offering price of $10.00 per share, for gross proceeds of $18.0 million, before deducting underwriting discounts and offering expenses. In addition, Virpax has granted the underwriters a 30-day option to purchase up to an additional 270,000 shares of common stock to cover over-allotments at the initial public offering price, less the underwriting discount. All of the shares of common stock are being offered by the Company.